Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
18.05
0.00 (0.00%)
Aug 13, 2025, 4:00 PM - Market open
Travere Therapeutics Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$33.40
Upside
+85.04%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $30 → $31 | Buy | Maintains | $30 → $31 | +71.75% | Aug 7, 2025 |
| Wedbush | Wedbush | Buy Maintains $30 → $32 | Buy | Maintains | $30 → $32 | +77.29% | Aug 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +66.20% | Jul 1, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $35 → $32 | Strong Buy | Maintains | $35 → $32 | +77.29% | Jun 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +66.20% | Jun 11, 2025 |
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +66.20% | May 16, 2025 |
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +66.20% | May 2, 2025 |
| Stifel | Stifel | Hold Maintains $22 → $23 | Hold | Maintains | $22 → $23 | +27.42% | May 2, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 23, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +160.39% | Apr 14, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $45 → $47 | Strong Buy | Maintains | $45 → $47 | +160.39% | Apr 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 3, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $29 → $31 | Strong Buy | Maintains | $29 → $31 | +71.75% | Apr 1, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $42 → $44 | Buy | Maintains | $42 → $44 | +143.77% | Feb 26, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $31 → $35 | Strong Buy | Maintains | $31 → $35 | +93.91% | Feb 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Feb 21, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.